Molecule intelOpportunity: ModerateEssential

Sevoflurane

17 brands · 15 companies · product forms

ATC: N01AB08 1 DRAP alert

Opportunity snapshot

Launch attractiveness
38
Market saturation
38
Price room
64
Regulatory risk
50
17
brands
15
companies
Rs 11,978.45
median price
13
price points
3.54x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 18%

Price room

Across observed sources and strengths
CheapestRs 7,013.25
MedianRs 11,978.45
Most expensiveRs 24,811.87
Spread3.54×
Sources: DRAP-official, Servaid

max/min price ratio 3.54x across 13 trusted points (Rs 7013.25-24811.87). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Sevoflurane — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2023-07-25
Rapid Alert; Drug Product: Falsified Sojourn ( Sevoflurane) Liquid For Inhalation

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(64) + 20% low-competition(62) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

15 canonical companies and 17 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.54x across 13 trusted points (Rs 7013.25-24811.87). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2023-07-25 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.